Jarvest R L, Berge J M, Houge-Frydrych C S, Mensah L M, O'Hanlon P J, Pope A J
GlaxoSmithKline Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, CM19 5AW, Essex, UK.
Bioorg Med Chem Lett. 2001 Sep 17;11(18):2499-502. doi: 10.1016/s0960-894x(01)00475-9.
Carbocyclic analogues of the microbial metabolite SB-219383 have been synthesised and evaluated as inhibitors of bacterial tyrosyl tRNA synthetase. One compound showed highly potent and selective nanomolar inhibition.
已合成了微生物代谢产物SB - 219383的碳环类似物,并将其作为细菌酪氨酸tRNA合成酶的抑制剂进行了评估。一种化合物表现出高效且选择性的纳摩尔级抑制作用。